CIK 0001773751
- Large accelerated filer
Hims & Hers Health, Inc.
Sign in to watch- Ticker
- HIMS
- Exchange
- NYSE
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 415-851-0195
- Business address
- 2269 CHESTNUT ST, #523, SAN FRANCISCO, CA, 94123
- Former names
- Oaktree Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,483,933
- in 10 filings, $2.5M under 10b5-1 plans
Net −$2,483,933. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-15 | Okupe Oluyemi Chief Financial Officer | Exercise or conversion 10b5-1 | +5,889 | $11.53 | $68K | 124,849 |
| 2025-05-15 | Okupe Oluyemi Chief Financial Officer | Exercise or conversion 10b5-1 | +548 | $5.01 | $3K | 125,397 |
| 2025-05-15 | Okupe Oluyemi Chief Financial Officer | Sale 10b5-1 | −11,581 | $60.22 | $697K | 113,816 |
| 2025-05-15 | Okupe Oluyemi Chief Financial Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −5,889 | 58,443 | ||
| 2025-05-15 | Okupe Oluyemi Chief Financial Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −548 | 398,748 | ||
| 2025-05-12 | Elshenawy Mohamed Chief Technology Officer | Grant or award · Restricted Stock Unit | +1,036,339 | 1,036,339 | ||
| 2025-05-12 | Baird Melissa Chief Operating Officer | Exercise or conversion 10b5-1 | +33,333 | $2.43 | $81K | 838,416 |
| 2025-05-12 | Baird Melissa Chief Operating Officer | Sale 10b5-1 | −13,786 | $54.98 | $758K | 824,630 |
| 2025-05-12 | Baird Melissa Chief Operating Officer | Sale 10b5-1 | −6,801 | $55.86 | $380K | 817,829 |
| 2025-05-12 | Baird Melissa Chief Operating Officer | Sale 10b5-1 | −7,556 | $56.80 | $429K | 810,273 |
| 2025-05-12 | Baird Melissa Chief Operating Officer | Sale 10b5-1 | −5,190 | $57.87 | $300K | 805,083 |
| 2025-05-12 | Baird Melissa Chief Operating Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −33,333 | 693,795 | ||
| 2025-05-12 | Boughton Soleil Chief Legal Officer | Sale 10b5-1 | −3,235 | $56.00 | $181K | 156,427 |
| 2025-04-29 | Dudum Andrew Chief Executive Officer | Exercise or conversion 10b5-1 | +50,000 | $2.43 | $122K | 142,103 |
| 2025-04-29 | Dudum Andrew Chief Executive Officer | Sale 10b5-1 | −50,000 | $36.39 | $1.8M | 92,103 |
| 2025-04-29 | Dudum Andrew Chief Executive Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −50,000 | 1,081,399 | ||
| 2025-04-28 | Boughton Soleil Chief Legal Officer | Sale 10b5-1 | −3,236 | $30.19 | $98K | 159,662 |
| 2025-04-28 | Dudum Andrew Chief Executive Officer | Exercise or conversion 10b5-1 | +41,667 | $2.43 | $101K | 133,770 |
| 2025-04-28 | Dudum Andrew Chief Executive Officer | Sale 10b5-1 | −41,667 | $30.19 | $1.3M | 92,103 |
| 2025-04-28 | Dudum Andrew Chief Executive Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −41,667 | 1,131,399 |
Page 35 of 37 · 739 trades